Short-term ketone monoester supplementation improves cerebral blood flow and cognition in obesity: A randomized cross-over trial

Jeremy J Walsh, Hannah G Caldwell, Helena Neudorf, Philip N Ainslie, Jonathan P Little, Jeremy J Walsh, Hannah G Caldwell, Helena Neudorf, Philip N Ainslie, Jonathan P Little

Abstract

Adults with obesity are at increased risk of neurocognitive impairments, partly as a result of reduced cerebral blood flow and brain-derived neurotrophic factor (BDNF). Ketone supplements containing β-hydroxybutyrate (β-OHB) are a purported therapeutic strategy for improving brain health in at-risk populations. We tested the hypothesis that short-term β-OHB supplementation will elevate cerebral blood flow and BDNF, as well as improve cognition in adults with obesity. In a placebo-controlled double-blind, cross-over design, 14 adults with obesity (10 females; aged 56 ± 12 years; body mass index = 33.8 ± 6.9 kg m-2 ) consumed 30 mL (12 g) of β-OHB or placebo thrice-daily for 14 days. Blood flow (Q) and cerebrovascular conductance (CVC) were measured in the common carotid (CCA), internal carotid (ICA) and vertebral (VA) arteries by duplex ultrasound. BDNF was measured by an enzyme-linked immunosorbent assay. Cognition was assessed by the digit-symbol substitution (DSST), Stroop and task-switching tests. Following 14 days of ketone supplementation, we observed significant improvements in cerebrovascular outcomes including QCCA (+12%), QVA (+11%), VACVC (+12%) and VA shear rate (+10%). DSST performance significantly improved following ketone supplementation (+2.7 correct responses) and improved DSST performance was positively associated improvements in cerebrovascular outcomes including QCCA , CCACVC , QVA and VACVC . By contrast to one hypothesis, β-OHB did not impact fasting serum and plasma BDNF. β-OHB supplementation improved cognition in adults with obesity, which may be partly facilitated by improvements in cerebral blood flow. β-OHB supplementation was well-tolerated and appears to be safe for cerebrovascular health, suggesting potential therapeutic benefits of β-OHB in a population at risk of neurocognitive impairment. KEY POINTS: People with obesity are at increased risk of neurocognitive dysfunction, partly as a result of -induced reductions in cerebral blood flow (CBF) and brain-derived neurotrophic factor (BDNF). Ketone supplements containing β-hydroxybutyrate (β-OHB) reduce postprandial hyperglycaemia, which may increase CBF and BDNF, thereby protecting against obesity-related cognitive dysfunction. We show for the first time that 14 days of thrice-daily β-OHB supplementation improves aspects of cognition and increases cerebrovascular flow, conductance and shear rate in the extracranial arteries of adults with obesity. Our preliminary data indicate a significant positive relationship between elevated CBF and improved cognition following β-OHB supplementation. This trial provides a foundation for the potential non-pharmacological therapeutic application of β-OHB supplementation in patient groups at risk of hyperglycaemic cerebrovascular disease and cognitive dysfunction.

Trial registration: ClinicalTrials.gov NCT03817749.

Keywords: BDNF; cerebrovascular; double-blind; executive functions; intervention; placebo-controlled; β-hydroxybutyrate.

© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

References

    1. Alosco ML & Gunstad J (2014). The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms. Curr Diab Rep 14, 495.
    1. Amadio P, Sandrini L, Ieraci A, Tremoli E & Barbieri SS (2017). Effect of clotting duration and temperature on BDNF measurement in human serum. Int J Mol Sci 18, 1987.
    1. American Diabetes Association (2020). Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43, S14-S31.
    1. Arentoft A, Sweat V, Starr V, Oliver S, Hassenstab J, Bruehl H, Tirsi A, Javier E, McHugh PF & Convit A (2009). Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain Cogn 71, 147-152.
    1. Carr J, Hoiland RL, Caldwell HG, Coombs GB, Howe CA, Tremblay JC, Green DJ & Ainslie PN (2020). Internal carotid and brachial artery shear-dependent vasodilator function in young healthy humans. J Physiol 598, 5333-5350.
    1. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M & Giugliano D (2008). Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57, 1349-1354.
    1. Clarke K, Tchabanenko K, Pawlosky R, Carter E, King M, Musa-Veloso K, Ho M, Roberts A, Robertson J, VanItallie T & Veech R (2012a). Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63, 401-408.
    1. Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, Ho M, Roberts A, Robertson J, VanItallie TB & Veech RL (2012b). Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63, 401-408.
    1. Convit A, Wolf OT, Tarshish C & De Leon MJ (2003). Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 100, 2019-2022.
    1. Croteau E, Castellano CAA, Fortier M, Bocti C, Fulop T, Paquet N & Cunnane SCC (2017). A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Exp Gerontol 107, 18-26. .
    1. Duckrow RB (1995). Decreased cerebral blood flow during acute hyperglycemia. Brain Res 703, 145-150.
    1. Duckrow RB, Beard DC & Brennan RW (1987). Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18, 52-58.
    1. Erickson KI, Miller DL & Roecklein KA (2012). The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist 18, 82-97.
    1. Fortier M, Castellano CA, Croteau E, Langlois F, Bocti C, St-Pierre V, Vandenberghe C, Bernier M, Roy M, Descoteaux M, Whittingstall K, Lepage M, Turcotte ÉE, Fulop T & Cunnane SC (2019). A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer's Dement 15, 625-634.
    1. Gratton G, Weaver SR, Burley C V., Low KA, Maclin EL, Johns PW, Pham QS, Lucas SJE, Fabiani M & Rendeiro C (2020). Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults. Sci Rep 10, 1-13.
    1. Griffin É́W, Bechara RG, Birch AM & Kelly Á́M (2009). Exercise enhances hippocampal-dependent learning in the rat: evidence for a BDNF-related mechanism. Hippocampus 19, 973-980.
    1. Habas K & Shang L (2018). Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue Cell 54, 139-143.
    1. Han Y, Bedarida T, Ding Y, Somba BK, Lu Q, Wang Q, Song P & Zou M-H (2018). β-Hydroxybutyrate prevents vascular senescence through hnRNP A1-mediated upregulation of Oct4. Mol Cell 71, 1064-1078.e5. e5.
    1. Harris JA & Benedict FG (1918). A biometric study of human basal metabolism. Proc Natl Acad Sci 4, 370-373.
    1. Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S & Paulson OB (1996). Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol Metab 270, E746-E751.
    1. Hendrikse J, Van Der Grond J, Lu H, Van Zijl PCM & Golay X (2004). Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke 35, 882-887.
    1. Hu E, Du H, Zhu X, Wang L, Shang S, Wu X, Lu H & Lu X (2018). Beta-hydroxybutyrate promotes the expression of BDNF in hippocampal neurons under adequate glucose supply. Neuroscience 386, 315-325.
    1. Jaeger J (2018). Digit symbol substitution test. J Clin Psychopharmacol 38, 513-519.
    1. Jensen NJ, Nilsson M, Ingerslev JS, Olsen DA, Fenger M, Svart M, Møller N, Zander M, Miskowiak KW & Rungby J (2020). Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes. Eur J Endocrinol 182, 233-242.
    1. Jones B & Kenward MG (2014). Design and analysis of cross-over trials, Third. Chapman and Hall, Boca Raton, FL.
    1. Kim J, Whyte J, Wang J, Rao H, Tang KZ & Detre JA (2006). Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks. Neuroimage 31, 376-385.
    1. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, Kobayashi M, Hirasawa A & Tsujimoto G (2011). Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci 108, 8030-8035.
    1. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H & Pedersen BK (2007). Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50, 431-438.
    1. Marosi K, Kim SW, Moehl K, Scheibye-Knudsen M, Cheng A, Cutler R, Camandola S & Mattson MP (2016). 3-Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons. J Neurochem 139, 769-781.
    1. Marosi K & Mattson MP (2014). BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25, 89-98.
    1. Mikkelsen KH, Seifert T, Secher NH, Grøndal T & Van Hall G (2015). Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-β-hydroxybutyratemia in post-absorptive healthy males. J Clin Endocrinol Metab 100, 636-643.
    1. Mujica-Parodi LR, Amgalan A, Sultan SF, Antal B, Sun X, Skiena S, Lithen A, Adra N, Ratai EM, Weistuch C, Govindarajan ST, Strey HH, Dill KA, Stufflebeam SM, Veech RL & Clarke K (2020). Diet modulates brain network stability, a biomarker for brain aging, in young adults. Proc Natl Acad Sci U S A 117, 6170-6177.
    1. Myette-Côté É, Caldwell HG, Ainslie PN, Clarke K & Little JP (2019). A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial. Am J Clin Nutr 110, 1491-1501.
    1. Myette-Côté É, Neudorf H, Rafiei H, Clarke K & Little JP (2018). Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals. J Physiol 596, 1385-1395.
    1. Neptune EM (1956). Changes in blood glucose during metabolism of ß hydroxybutyrate. Am J Physiol Content 187, 451-453.
    1. Newman JC & Verdin E (2014). β-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract 106, 173-181.
    1. Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, Esposito K, Szabó C & Ceriello A (2004). Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: The role of poly(ADP-ribose) polymerase. J Thromb Haemost 2, 1453-1459.
    1. Polacchini A, Metelli G, Francavilla R, Baj G, Florean M, Mascaretti LG & Tongiorgi E (2015). A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays. Sci Rep 5, 1-10.
    1. Prickett C, Stolwyk R, O'Brien P & Brennan L (2018). Neuropsychological functioning in mid-life treatment-seeking adults with obesity: a cross-sectional study. Obes Surg 28, 532-540.
    1. Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, Pokorná B, Vollbrandt T, Stölting I, Nadrowitz R, Okun JG, Offermanns S & Schwaninger M (2014). The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5, 3944.
    1. Shemesh D, Bokobza N, Rozenberg K, Rosenzweig T & Abookasis D (2019). Decreased cerebral blood flow and hemodynamic parameters during acute hyperglycemia in mice model observed by dual-wavelength speckle imaging. J Biophotonics 12, 201900002. .
    1. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese R V., De Cabo R, Ulrich S, Akassoglou K & Verdin E (2013). Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (80-) 339, 211-214.
    1. Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Haidar EA, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I & Chao MV (2016). Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body $β$- hydroxybutyrate. Elife 5, 1-21.
    1. Soto-Mota A, Vansant H, Evans RD & Clarke K (2019). Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults. Regul Toxicol Pharmacol 109, 104506.
    1. Sun ZC, Yu J, Liu YL, Hong ZZ, Ling L, Li GQ, Zhuo YF, Wang WR & Zhang Y (2018). Reduced serum levels of brain-derived neurotrophic factor are related to mild cognitive impairment in Chinese patients with type 2 diabetes mellitus. Ann Nutr Metab 73, 271-281.
    1. Svart M, Gormsen LC, Hansen J, Zeidler D, Gejl M, Vang K, Aanerud J & Moeller N (2018). Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial. PLoS One 13, 1-12.
    1. The Lancet (2010). CONSORT 2010. Lancet 375, 1136.
    1. Thomas KN, Lewis NCS, Hill BG & Ainslie PN (2015). Technical recommendations for the use of carotid duplex ultrasound for the assessment of extracranial blood flow. Am J Physiol Regul Integr Comp Physiol 309, R707-R720.
    1. Usui N, Haji T, Maruyama M, Katsuyama N, Uchida S, Hozawa A, Omori K, Tsuji I, Kawashima R & Taira M (2009). Cortical areas related to performance of WAIS Digit Symbol Test: a functional imaging study. Neurosci Lett 463, 1-5.
    1. Vlassenko AG, Rundle MM, Raichle ME & Mintun MA (2006). Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ ratio. Proc Natl Acad Sci 103, 1964-1969.
    1. Walsh JJ, Myette-Côté É & Little JP (2020). The effect of exogenous ketone monoester ingestion on plasma BDNF during an oral glucose tolerance test. Front Physiol 11, 10-94. .
    1. Walsh JJ, Neudorf H & Little JP (2021). 14-day ketone supplementation lowers glucose and improves vascular function in obesity: a randomized crossover trial. J Clin Endocrinol Metab 106, e1738-e1754.
    1. Walsh JJ & Tschakovsky ME (2018). Exercise and circulating BDNF: mechanisms of release and implications for the design of exercise interventions. Appl Physiol Nutr Metab 43, 1095-1104.
    1. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, Puddey IB, Beilin LJ, Burke V, Mori TA & Green D (2001). Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol 91, 929-937.
    1. Wu X, Miao D, Liu Z, Liu K, Zhang B, Li J, Li Y & Qi J (2020). β-hydroxybutyrate antagonizes aortic endothelial injury by promoting generation of VEGF in diabetic rats. Tissue Cell 64, 101345.
    1. Xin L, Ipek Ö, Beaumont M, Shevlyakova M, Christinat N, Masoodi M, Greenberg N, Gruetter R & Cuenoud B (2018). Nutritional ketosis increases NAD+/NADH ratio in healthy human brain: an in vivo study by 31P-MRS. Front Nutr 5, 1-8.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe